Bogart Wealth LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $135K | Sell |
2,344
-40
| -2% | -$2.3K | ﹤0.01% | 341 |
|
|
2026
Q1 | $145K | Sell |
2,384
-213
| -8% | -$12.4K | 0.01% | 312 |
|
|
2025
Q4 | $140K | Sell |
2,597
-1,024
| -28% | -$49.3K | 0.01% | 294 |
|
|
2025
Q3 | $163K | Buy |
3,621
+10
| +0.3% | +$467 | 0.01% | 270 |
|
|
2025
Q2 | $167K | Sell |
3,611
-401
| -10% | -$19.7K | 0.01% | 259 |
|
|
2025
Q1 | $245K | Sell |
4,012
-28
| -0.7% | -$1.63K | 0.01% | 205 |
|
|
2024
Q4 | $229K | Buy |
4,040
+508
| +14% | +$28.4K | 0.01% | 207 |
|
|
2024
Q3 | $183K | Buy |
3,532
+24
| +0.7% | +$1.13K | 0.01% | 221 |
|
|
2024
Q2 | $146K | Sell |
3,508
-110,402
| -97% | -$4.94M | 0.01% | 241 |
|
|
2024
Q1 | $6.18M | Buy |
113,910
+2,836
| +3% | +$144K | 0.32% | 76 |
|
|
2023
Q4 | $5.7M | Buy |
111,074
+20,789
| +23% | +$1.09M | 0.32% | 79 |
|
|
2023
Q3 | $5.24M | Buy |
90,285
+1,130
| +1% | +$69.2K | 0.32% | 79 |
|
|
2023
Q2 | $5.7M | Buy |
89,155
+2,898
| +3% | +$194K | 0.36% | 72 |
|
|
2023
Q1 | $5.98M | Buy |
86,257
+7,593
| +10% | +$536K | 0.4% | 63 |
|
|
2022
Q4 | $5.66M | Buy |
78,664
+76,547
| +3,616% | +$5.77M | 0.39% | 59 |
|
|
2022
Q3 | $151K | Buy |
2,117
+59
| +3% | +$4.28K | 0.01% | 187 |
|
|
2022
Q2 | $158K | Buy |
2,058
+5
| +0.2% | +$381 | 0.01% | 172 |
|
|
2022
Q1 | $150K | Hold |
2,053
| – | – | 0.01% | 179 |
|
|
2021
Q4 | $128K | Sell |
2,053
-101
| -5% | -$5.92K | 0.01% | 177 |
|
|
2021
Q3 | $127K | Buy |
2,154
+1
| +0% | +$66 | 0.01% | 173 |
|
|
2021
Q2 | $144K | Sell |
2,153
-179
| -8% | -$11.7K | 0.02% | 161 |
|
|
2021
Q1 | $147K | Buy |
2,332
+780
| +50% | +$48.5K | 0.02% | 148 |
|
|
2020
Q4 | $96K | Buy |
1,552
+45
| +3% | +$2.77K | 0.02% | 159 |
|
|
2020
Q3 | $90K | Hold |
1,507
| – | – | 0.02% | 154 |
|
|
2020
Q2 | $89K | Hold |
1,507
| – | – | 0.02% | 142 |
|
|
2020
Q1 | $84K | Hold |
1,507
| – | – | 0.02% | 144 |
|
|
2019
Q4 | $97K | Sell |
1,507
-91
| -6% | -$5.21K | 0.03% | 143 |
|
|
2019
Q3 | $81K | Buy |
1,598
+26
| +2% | +$1.22K | 0.04% | 131 |
|
|
2019
Q2 | $71K | Hold |
1,572
| – | – | 0.04% | 125 |
|
|
2019
Q1 | $75K | Sell |
1,572
-30
| -2% | -$1.49K | 0.04% | 118 |
|
|
2018
Q4 | $83K | Hold |
1,602
| – | – | 0.04% | 110 |
|
|
2018
Q3 | $99K | Hold |
1,602
| – | – | 0.06% | 104 |
|
|
2018
Q2 | $88K | Sell |
1,602
-26
| -2% | -$1.4K | 0.05% | 107 |
|
|
2018
Q1 | $101K | Sell |
1,628
-1,151
| -41% | -$74K | 0.06% | 97 |
|
|
2017
Q4 | $170K | Buy |
2,779
+120
| +5% | +$7.51K | 0.11% | 74 |
|
|
2017
Q3 | $171K | Buy |
+2,659
| New | +$155K | 0.13% | 68 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Bogart Wealth LLC's BMY Position: Q2 2026 in Review
Bogart Wealth LLC reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $2.3K and leaving 2,344 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #341.
Bogart Wealth LLC first reported a position in BMY in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.18M in Q1 2024. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bogart Wealth LLC held 2,344 shares of Bristol-Myers Squibb worth $135K as of Q2 2026.
- Bogart Wealth LLC sold 40 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.3K.
- Bristol-Myers Squibb made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #341 holding.
- Bogart Wealth LLC first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 36 quarters since.
- Bogart Wealth LLC's Bristol-Myers Squibb position peaked at $6.18M in Q1 2024.
- 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.